English   español  
Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/153065
Share/Impact:
Statistics
logo share SHARE logo core CORE   Add this article to your Mendeley library MendeleyBASE

Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL
Exportar a otros formatos:

Title

Neuromuscular Junction Impairment in Amyotrophic Lateral Sclerosis: Reassessing the Role of Acetylcholinesterase

AuthorsCampanari, María Letizia; García Ayllón, María Salud; Ciura, Sorana; Sáez-Valero, Javier; Kabashi, Edor
Issue Date27-Dec-2016
PublisherFrontiers Media
CitationFront. Mol. Neurosci. 9: 160 (2016)
AbstractAmyotrophic Lateral Sclerosis (ALS) is a highly debilitating disease caused by progressive degeneration of motorneurons (MNs). Due to the wide variety of genes and mutations identified in ALS, a highly varied etiology could ultimately converge to produce similar clinical symptoms. A major hypothesis in ALS research is the “distal axonopathy” with pathological changes occurring at the neuromuscular junction (NMJ), at very early stages of the disease, prior to MNs degeneration and onset of clinical symptoms. The NMJ is a highly specialized cholinergic synapse, allowing signaling between muscle and nerve necessary for skeletal muscle function. This nerve-muscle contact is characterized by the clustering of the collagen-tailed form of acetylcholinesterase (ColQ-AChE), together with other components of the extracellular matrix (ECM) and specific key molecules in the NMJ formation. Interestingly, in addition to their cholinergic role AChE is thought to play several “non-classical” roles that do not require catalytic function, most prominent among these is the facilitation of neurite growth, NMJ formation and survival. In all this context, abnormalities of AChE content have been found in plasma of ALS patients, in which AChE changes may reflect the neuromuscular disruption. We review these findings and particularly the evidences of changes of AChE at neuromuscular synapse in the pre-symptomatic stages of ALS.
Publisher version (URL)http://dx.doi.org/10.3389/fnmol.2016.00160
URIhttp://hdl.handle.net/10261/153065
DOI10.3389/fnmol.2016.00160
ISSN1662-5099
Appears in Collections:(IN) Artículos
Files in This Item:
File Description SizeFormat 
Neuromuscular Junction Impairment in Amyotrophic Lateral Sclerosis.pdf1,37 MBAdobe PDFThumbnail
View/Open
Show full item record
Review this work
 

Related articles:


WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.